AlopeciAI aims to estimate hair-loss progression over five to ten years. Here is how to assess the claim before it shapes a clinical decision.
On October 26, 2026, The Manila Times carried a Plentisoft press release about Advanced Hair Clinics’ development-stage hair-loss estimation tool AlopeciAI. The clinic had presented the tool at an Athens workshop on September 8, 2026.
The clinic’s announcement sets out a proposed role for the tool in hair-loss assessment. These are the main points reported in the release:
Clinic founder Dr. Anastasios Vekris introduced the tool at the workshop. The release identifies him as a plastic surgeon.
This is a promotional announcement rather than independent reporting or a clinical validation study. It provides no accuracy or validation results for AlopeciAI. That leaves the tool’s actual predictive performance unresolved.
The stated period of five to ten years is a forecasting horizon, not a measure of precision. The release says estimates beyond that period carry greater uncertainty. It does not quantify uncertainty within the proposed window.
Nor does the announcement report improved hair density or broader health benefits from using AlopeciAI. A forecast is an estimate of what may happen, not evidence that using it changes the outcome. The useful response is to ask what would make the estimate informative in an actual consultation.
For a gay man over 35, the relevant question is not whether AI sounds advanced. It is whether an estimate helps answer a specific concern about his hair without taking over the decision.
You might care most about a receding hairline, overall appearance or whether to discuss a transplant. Those are legitimate aesthetic concerns. They do not require treating a younger appearance as the only acceptable outcome.
Separate the questions before assessing the technology:
The first question calls for assessment. The second describes AlopeciAI’s proposed purpose. The third belongs in a conversation with a qualified clinician rather than being settled by a projection.
That distinction keeps the tool in proportion. Treat it as a discussion prompt rather than an instruction to spend money or commit to a procedure. Confidence in a decision should come from understanding the evidence and the choices available, not from how polished the presentation looks.
A forecast asks about the future. Diagnosis asks what is happening now and why.
The American Academy of Dermatology describes hair-loss diagnosis as a process of identifying the cause. It includes taking a history and examining the scalp and hair. Blood tests or a scalp biopsy may be considered when findings suggest an underlying condition.
The AAD lists disease and deficiency among possible reasons for further investigation. It also includes hormone imbalance and infection. This is a reason for clinician-led assessment, not a checklist for self-diagnosis.
The clinic’s own release also places examination and history within hair-loss assessment. It says its process includes reviewing medical and family history alongside diet and hair-care routine. Blood tests or a pull test may be used depending on the findings.
For the reader, the practical preparation is a clear account of the concern and relevant history. Questions about diet or grooming belong in that account rather than becoming automatic explanations for the problem.
GayFitLab’s overview of assessing hair loss after 35 gives a wider frame for the conversation. Personal diagnostic and treatment decisions belong with a qualified clinician.
Before allowing an estimate to influence a medical or aesthetic decision, ask the clinician to explain what sits behind it. The following questions are an editorial way to assess the proposal, not a list of verified AlopeciAI features.
These questions do not require technical expertise. They require an explanation that connects a tool’s output with a real decision. A useful consultation leaves room to discuss why a projection matters rather than allowing the projection to become the entire consultation.
For a broader method of separating evidence from presentation, GayFitLab’s guide to reading aesthetic claims applies the same research-first perspective.
No. The clinic describes its existing AI-assisted surgical planning separately from the development-stage AlopeciAI tool.
According to the release, that surgical planning considers hairline design and graft allocation. Broader transplant planning also takes account of donor-area potential and available grafts. Age and face shape are considered alongside the patient’s goals.
Those are different tasks from estimating future hair-loss progression. A planning process addresses choices about a proposed procedure. A progression estimate addresses a possible future course.
If transplantation is part of your conversation, ask the clinician to distinguish those roles clearly. Establish which information is being used for design and which is being offered as a forecast. Then discuss how each relates to the plan being proposed.
The point is not to reject technology. It is to avoid letting the broad label “AI” blur separate tools and separate decisions.
The practical change is in how you judge a claim, not in adding another grooming step. Keep questions about treatment with a qualified clinician and connect appearance goals to that discussion.
A forecast should not become a shopping list. Before paying for a product or committing to a procedure on the strength of an estimate, ask what clinical findings support the recommendation and what outcome is being proposed.
For healthspan, keep the categories separate. This announcement concerns hair-loss estimation. The discussion about long-term health still needs its own evidence rather than borrowing authority from a tool concerned with future hair changes.
Your priorities can include looking polished and feeling comfortable with your appearance. They can also include the time and attention you want to spend on your hair. An adult decision gives those preferences room without treating a forecast as an obligation to change your looks.
Bring the conversation back to a practical question: what, if anything, would this estimate change about a clinician’s advice? That keeps a futuristic claim connected to a decision you actually face.
Treat AlopeciAI as a prompt for a cause-focused clinical conversation and ask for evidence behind its estimates before allowing a long-term forecast to shape treatment or transplant decisions.
A man weighing hair-loss claims remains in charge of his appearance choices, while GayFitLab brings research-led clarity to the information behind them. Its coverage helps gay men 35+ distinguish useful hair and aesthetic evidence from beauty marketing without prescribing one look or turning healthy aging into a pursuit of youth.
Stay connected for research-led guidance on fitness, body composition, skin, grooming, vitality, sexual wellbeing, relationships and healthy aging. Clear ideas for gay men 35+ who want to look good, feel strong and age with confidence.
Build habits and systems that support clear thinking, steady energy and long term capacity throughout a demanding career.
explore the Blog
